| Literature DB >> 28835362 |
Masaomi Gohbara1, Azusa Hayakawa2, Yusuke Akazawa2, Shuta Furihata2, Ai Kondo2, Yusuke Fukushima2, Sakie Tomari2, Tsutomu Endo2, Kazuo Kimura3, Kouichi Tamura4.
Abstract
BACKGROUND: Contrast-induced nephropathy (CIN) is associated with poor outcomes in patients with acute myocardial infarction. However, the predictors of CIN have yet to be fully elucidated. METHODS ANDEntities:
Keywords: ST‐segment elevation myocardial infarction; acidosis; contrast‐induced nephropathy
Mesh:
Substances:
Year: 2017 PMID: 28835362 PMCID: PMC5586466 DOI: 10.1161/JAHA.117.006380
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Study flow chart. Of the 331 screened patients, 273 were enrolled in the present study. CABG indicates coronary artery bypass grafting; STEMI, ST‐segment elevation myocardial infarction.
Baseline and Clinical Characteristics
| Variables | With CIN (n=35) | Without CIN (n=238) |
|
|---|---|---|---|
| Age, y | 75 (64–80) | 68 (60–76) | 0.041 |
| Male, n (%) | 27 (77) | 188 (79) | 0.803 |
| Body mass index, kg/m2 | 23 (22–25) | 24 (22–26) | 0.708 |
| Killip class >1, n (%) | 8 (23) | 25 (11) | 0.050 |
| Reperfusion time, h | 3.9 (2.4–6.0) | 2.8 (2.0–4.0) | 0.004 |
| Culprit artery | 0.422 | ||
| Left anterior descending artery, n (%) | 20 (57) | 113 (47) | |
| Right coronary artery, n (%) | 9 (26) | 88 (37) | |
| Left circumflex artery, n (%) | 6 (17) | 37 (16) | |
| Number of diseased vessels, n (%) | 0.411 | ||
| 1 | 15 (43) | 123 (51) | |
| 2 | 15 (43) | 75 (32) | |
| 3 | 5 (14) | 40 (17) | |
| Amount of contrast medium, mL | 133 (100–200) | 135 (104–160) | 0.970 |
| Current smoker, n (%) | 15 (43) | 88 (37) | 0.503 |
| Hypertension, n (%) | 27 (77) | 128 (54) | 0.009 |
| Dyslipidemia, n (%) | 25 (71) | 195 (82) | 0.142 |
| Diabetes mellitus, n (%) | 11 (31) | 68 (29) | 0.728 |
| Glucose level on admission, mg/dL | 192 (153–213) | 152 (125–201) | 0.004 |
| Hemoglobin A1c, % | 5.8 (5.7–6.6) | 6.0 (5.7–6.5) | 0.614 |
| Peak CPK, IU/L | 2323 (1298–6142) | 1535 (695–3112) | 0.012 |
| Peak CK‐MB, IU/L | 233 (184–599) | 172 (74–334) | 0.008 |
| hs‐CRP on admission, mg/dL | 0.20 (0.07–0.94) | 0.10 (0.05–0.25) | 0.008 |
| Serum creatinine, mg/dL | 0.82 (0.64–1.27) | 0.90 (0.80–1.05) | 0.305 |
| eGFR on admission, mL/min per 1.73 m2 | 68 (43–84) | 63 (52–71) | 0.451 |
| Acidosis, n (%) | 12 (34) | 40 (17) | 0.014 |
| Metabolic acidosis, n (%) | 7 (20) | 20 (8) | 0.061 |
| Respiratory acidosis, n (%) | 5 (14) | 8 (3) | 0.016 |
| LVEF, % | 55 (47–60) | 57 (51–62) | 0.049 |
| DcT, ms | 191 (169–217) | 209 (172–259) | 0.144 |
| Mehran risk score | 6 (4–11) | 4 (1–8) | 0.022 |
Data are displayed as mean±SD or number (percentage) or median (range). CIN indicates contrast‐induced nephropathy; CK‐MB, creatine kinase MB; CPK, creatine phosphokinase; DcT, deceleration time; eGFR, estimated glomerular filtration rate; hs‐CRP, high‐sensitivity C‐reactive protein; LVEF, left ventricular ejection fraction.
Figure 2The association between the incidence of CIN and in‐hospital mortality rate. In‐hospital mortality rate was higher in patients with CIN (11.4%, 4 of 35 patients) than that in patients without CIN (2.1%, 5 of 238 patients) (P=0.018). CIN indicates contrast‐induced nephropathy.
Univariate and Multivariable Logistic Regression Analyses to Predict CIN
| Variables | Univariate | Multivariable (Stepwise) | Multivariable (Forced Inclusion Model 1) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| OR | 95% CI |
| |
| Age, per 1 y | 1.030 | 1.000 to 1.062 | 0.051 | 0.227 | 1.034 | 1.000 to 1.069 | 0.053 | ||
| Male | 0.898 | 0.384 to 2.097 | 0.803 | Not selected | 1.299 | 0.522 to 3.229 | 0.574 | ||
| Body mass index, per 1 kg/m2 | 0.975 | 0.875 to 1.087 | 0.648 | Not selected | 1.016 | 0.902 to 1.145 | 0.618 | ||
| Killip class >1 | 2.524 | 1.035 to 6.154 | 0.042 | 0.664 | ··· | ||||
| Reperfusion time, per 1 h | 1.217 | 1.077 to 1.375 | 0.002 | 1.202 | 1.044 to 1.385 | 0.011 | ··· | ||
| Amount of contrast medium, per 1 mL | 1.001 | 0.994 to 1.008 | 0.740 | Not selected | ··· | ||||
| Hypertension | 2.900 | 1.266 to 6.645 | 0.012 | 3.168 | 1.292 to 7.772 | 0.012 | ··· | ||
| Dyslipidemia | 0.551 | 0.247 to 1.232 | 0.147 | 0.337 | ··· | ||||
| Glucose level on admission, per 1 mg/dL | 1.006 | 1.001 to 1.011 | 0.017 | 0.093 | ··· | ||||
| Peak CK‐MB, per 1 IU/L | 1.002 | 1.001 to 1.004 | 0.001 | 1.002 | 1.000 to 1.004 | 0.017 | ··· | ||
| hs‐CRP on admission, per 1 mg/dL | 1.246 | 1.025 to 1.514 | 0.027 | 1.245 | 1.034 to 1.498 | 0.020 | ··· | ||
| eGFR on admission, per 1 mL/min per 1.73 m2 | 1.005 | 0.986 to 1.026 | 0.592 | Not selected | ··· | ||||
| Acidosis | 2.583 | 1.188 to 5.613 | 0.017 | 2.713 | 1.113 to 6.616 | 0.028 | 2.548 | 1.160 to 5.593 | 0.020 |
| LVEF, % | 0.959 | 0.921 to 0.997 | 0.035 | 0.712 | ··· | ||||
| Mehran risk score | 1.081 | 1.016 to 1.150 | 0.014 | 0.458 | ··· | ||||
The table lists all the analyzed variables. Forced inclusion model 1: age, male, body mass index, and the incidence of acidosis. Forced inclusion model 2: amount of contrast medium, eGFR on admission, and the incidence of acidosis. Forced inclusion model 3: glucose level on admission, hs‐CRP on admission, the incidence of acidosis, and LVEF. Forced inclusion model 4: the incidence of acidosis and Mehran risk score. CI indicates confidence interval; CIN, contrast‐induced nephropathy; CK‐MB, creatine kinase MB; eGFR, estimated glomerular filtration rate; hs‐CRP, high‐sensitivity C‐reactive protein; LVEF, left ventricular ejection fraction; OR, odds ratio.